Skip to content

Researchers unlock 38-year-old mystery of the heart.

Researchers at the University of Alberta’s have explained how the function of a key protein in the heart changes in heart failure.  The study is published in the in Proceedings of the National Academy of Sciences.

The molecular structure of the heart muscle changes as heart failure progresses, though scientists cannot always agree on what changes are good or bad. One change that occurs is an increase in ‘calcium sensitivity’. Calcium ions are pumped in and out of the muscle cell with each heartbeat, turning contractions on and off. When the calcium sensitivity increases, contractility increases, but at a price; the relaxation of the heart becomes slower. Both phases of cardiac function are important, impaired contraction leads to systolic heart failure, while impaired relaxation leads to diastolic heart failure. Both types of heart failure are similar in terms of overall prevalence, symptoms and mortality.

Since 1976 medical researchers have known that the heart regulates its calcium sensitivity by phosphorylating (adding negative phosphate groups) to a key cardiac protein called troponin I. The troponin complex is made up of three proteins, C, I, and T, which trigger muscle contraction in response to calcium. In heart failure, the phosphate groups are removed from troponin I, but it wasn’t known how this caused an increase in calcium sensitivity.

In the current study the researchers studied the troponin complex with nuclear magnetic resonance (NMR) spectroscopy, a powerful method that uses superconducting magnets to probe atomic level structure. They observed that unphosphorylated troponin I binds to troponin C to keep it in an optimal orientation for triggering contraction. The (N-terminal) region of troponin I that interacts with troponin C is very positively charged, while troponin C is very negatively charged, so adding negative phosphate groups to troponin I disrupts the interaction and releases troponin C so that it becomes less efficient at triggering contraction.

Scientists believed that the dephosphorylation of troponin I seen in heart failure somehow caused the troponin complex to become less functional.  Actually, the change brings it into the optimal alignment to trigger contraction. The heart has other mechanisms of regulating calcium sensitivity that probably also act by stabilizing or disrupting this arrangement.

The team hypothesizes that the heart continuously adjusts calcium sensitivity in order to maintain a proper balance between contraction and relaxation.

The team believe that calcium sensitivity will become a central concept in cardiology. The increase in calcium sensitivity seen in heart failure may be the heart’s response to ongoing volume or pressure overload. While this would be a beneficial compensation in the setting of systolic heart failure, it is probably not helpful in diastolic heart failure.

Heart disease is the number-one killer in the developed world. The end stage of heart disease is heart failure, in which the heart cannot pump enough blood to satisfy the body’s needs. Patients become progressively short of breath as the condition worsens, and they also begin to accumulate fluid in the legs and lungs, making it even more difficult to breathe.

The team is now developing troponin-targeting drugs that modulate calcium sensitivity for the treatment of heart failure.

Source:  University of Alberta 

 

 Diagram of cardiac troponin complex.  Credit:  A Chaikhouni, H Al-Zaim 2007.
Diagram of cardiac troponin complex. Credit: A Chaikhouni, H Al-Zaim 2007.

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »